Sanofi Agrees to U.S. Antitrust Settlement Over Lantus
Sanofi agreed to a settlement in a U.S. antitrust lawsuit concerning its diabetes drug Lantus.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sanofi agreed to a settlement in a U.S. antitrust lawsuit concerning its diabetes drug Lantus.
Sanofi reached a tentative settlement of long-running claims by drug wholesalers alleging it used an improper patent listing to suppress competition for its diabetes treatment Lantus.